Education for Urology Professionals

For over 30 years, Grand Rounds in Urology has been a premier, trusted source of quality information and innovative educational tools for professionals in the fields of urology and radiation oncology. Our library contains over 1,000 videos and presentations.

Practice Resources for Urology Professionals

For over 30 years, Grand Rounds in Urology has been a premier, trusted source of quality information and innovative educational tools for professionals in the field of urology.

E. David Crawford, MD Editor-in-Chief

Join our Community

Latest Content Contributions

Our contributing faculty are leaders in their respective fields and drive innovations in urology. Explore their most recent additions.

2025 Medicare Part D Changes: Physician’s Perspective

Neal D. Shore, MD
Oct 2024

Mark N. Painter, MBS, Neal D. Shore, MD, FACS and David S. Morris, MD, FACS share the physician's view on the Medicare Part D changes.

PCa Commentary | Volume 194 – October 2024

Edward Weber, MD
Oct 2024

This commentary discusses how The EMBARK trial offers a useful model of options as to how to treat stage M0 patients who are at high risk for recurrence with rapidly rising PSA values.

2025 Medicare Part D Changes: Preparing Your Office and Patients

Mark N. Painter, CPMA, MBS
Oct 2024

Mark N. Painter, CPMA and Michael Burnett describe upcoming Medicare Part D changes and what that means for urology patients.

2025 Medicare Part D Changes: Overview of the 2025 Plan

Mark N. Painter, CPMA, MBS
Oct 2024

Mark N. Painter, CPMA describes upcoming Medicare Part D changes and what that means for urology patients.

Alan Partin Lecture: The Genomics and Natural History of Visible vs. Invisible Cancers

Laurence Klotz, MD, FRCSC
Oct 2024

Laurence Klotz, MD, FRCSC, argues that MRI visibility correlates with prostate tumor gene expression and aggressivity.

Putting Germline Testing into Context: A Primer and Current Knowledge

Alan H. Bryce, MD
Oct 2024

Alan H. Bryce, MD, explores applications and the latest advancements of germline testing in the context of prostate cancer.

Next Generation Learning Centers

The latest best practices from leading urologists, designed to create topic mastery.

Next Generation Men’s Health Learning Center

David Utz
Sep 2023

This Men's Health NGLC covers topics in Andrology, AUA Guidelines, Sexual Health, Incontinence, BPH, and other topics in Men's Health.

Next Generation Focal Therapy Learning Center

David Utz
Apr 2023

As a result of an increasing amount of clinical data, interest in focal ablation for the treatment of localized prostate cancer has grown immensely over the last fifteen years. We are Drs. Arvin George, Abhinav Sidana, and Jonathan S. Fainberg, internationally-recognized experts in focal therapy. As editors of the Grand Rounds in Urology Next Generation Focal...

Next Generation Microbiome and Urologic Infections

Rusty Speidel
Apr 2020

There is an abundance of evidence that the human microbiome plays an important and nuanced role in controlling human health, including metabolism, immunity, pain, psychological state, and cancer.

Next Generation Genomics and Biomarkers

Leonard G. Gomella, MD, FACS
Mar 2019

The role of genetic testing for prostate cancer risk is a rapidly changing area. Experts debate the indications of sending a patient on to genetic counseling for further potential screening for inherited prostate cancer risk. One major issue that needs to be addressed in the urology community today is recognizing the frequency of inherited mutations that...

Next Generation nmCRPC

David Utz
Dec 2018

Latest prostate cancer research is turning its focus on the M0 space. Many therapeutic options for castration-resistant prostate cancer are approved and used for metastatic castration-resistant prostate cancer (mCRPC), but fewer options exist for those with non-metastatic (NM) CRPC.

Next Generation Imaging

David Utz
Dec 2018

The role of imaging is paramount in this evolution by providing physicians with accurate information on both the presence and extent of prostate cancers. Developments in molecular imaging are paving the way for more physicians to diagnose cancer and apply relevant therapy.

Next Generation Androgen Deprivation Therapy

Celestia S. Higano, MD
Oct 2018

One of the major treatments for prostate cancer is androgen-deprivation therapy (ADT), and about 50% of prostate cancer patients are treated with ADT at some point in their disease. ADT is used most frequently for patients with local but advanced prostate cancer or metastatic prostate cancer.

Next Generation Nocturia

Kevin T. McVary, MD, FACS
Aug 2018

Nocturia is arguably the most bothersome lower urinary tract symptom and necessarily imposes a considerable burden on quality of life. The often-multifactorial etiologies contributing to nocturia obscure the establishment of a reliable diagnosis.

Bladder with low grade papillary urothelial carcinoma.

Next Generation UTUC

Seth P. Lerner, MD, FACS
Aug 2018

Upper tract urothelial carcinoma (UTUC) is cancer of the transitional urothelial cells that line the upper urothelial tract of the renal pelvis and ureter. This type of cancer accounts for between 5% and 10% of urothelial cancer cases.

Latest Features and Updates

Timely information from our GRU Editorial Team, such as newly published proceedings, upcoming events, and newsworthy activities from within the urology community.

Presentations from 1st International Functional and Reconstructive Urology Update

Sep 2024

These lectures were presented during the Presentations from 1st International Functional and Reconstructive Urology Update in August 2024, in Denver, Colorado.

Presentations from the 24th Annual Future Directions in Urology Symposium

Sep 2024

These lectures were presented during the 24th Annual Future Directions in Urology Symposium in August 2024, in Colorado Springs, Colorado.

An Expert Discussion of Testosterone Nadir and Clinical Outcomes in Patients with Advanced Prostate Cancer: A Post Hoc Analysis of Triptorelin Pamoate Phase III Studies

Jun 2024

In a program supported by Verity Pharmaceuticals, Neal D. Shore, MD, FACS, Medical Director for the Carolina Urologic Research Center and Chief Medical Officer, Strategic Growth and Pharmacy, GenesisCare US, Myrtle Beach, South Carolina, and Laurence Klotz, MD, FRCSC, Professor of Surgery at the University of Toronto and the Sunnybrook Chair of Prostate Cancer Research in...

Presentations from the 34th Annual International Prostate Cancer Update

Mar 2024

These lectures were presented during the 33rd Annual International Prostate Cancer Update in January 2023, in Vail, Colorado.

ADT is the Building Block for Advanced Prostate Cancer Therapy

Feb 2024

E. David Crawford, MD, Editor-in-Chief at Grand Rounds in Urology, leads a discussion on Androgen Deprivation Therapy (ADT) as the foundation for advanced prostate cancer treatment, supported by Verity Pharmaceuticals. Joining him in this discussion is: Scott B. Selinger, MD - President of the Advanced Urology Institute, Chair of the Advanced Urology Institute’s Advanced Prostate Cancer...

ADT as Foundational Therapy, and the Need for Consensus on Consistent T Suppression, Goals, Monitoring, and Delaying Time to CRPC

Feb 2023

In a program supported by Verity Pharmaceuticals, E. David Crawford, MD, Editor-in-Chief of Grand Rounds in Urology and Professor of Urology at the University of California, San Diego; Neal D. Shore, MD, FACS, Medical Director for the Carolina Urologic Research Center; and Benjamin H. Lowentritt, MD, FACS, Director of Prostate Cancer Services for United Urology Group...

Presentations from the 33rd Annual International Prostate Cancer Update

Feb 2023

These lectures were presented during the 33rd Annual International Prostate Cancer Update in January 2023, in Vail, Colorado.

Presentations from the 6th International Bladder Cancer Update

Dec 2022

These lectures were presented during the 6th Annual International Bladder Cancer Update on November 18, 2022, in Scottsdale, Arizona.

Presentations from the 2nd Annual Advances in Men’s Health

Oct 2022

These lectures were presented during the 2nd Annual Advances in Men's Health in August 2022, in Big Sky, Montana.

ADT Side Effects: Cardiovascular Disease

Aug 2022

In a program supported by Verity Pharmaceuticals, E. David Crawford, MD, Editor-in-Chief of Grand Rounds in Urology and Professor of Urology at the University of California, San Diego, discusses reinforcing consistent testosterone suppression in ADT and the role of triptorelin with Scott B. Sellinger, MD, President of Advanced Urology Institute and a Partner at Southeastern Urological...

Presentations from the 32nd Annual International Prostate Cancer Update

Apr 2022

These lectures were presented during the 32nd Annual International Prostate Cancer Update in March 2022, in Snowbird, Utah.

ADT as Foundational Therapy, and the Need for Consensus on Consistent T Suppression, Goals, Monitoring, and Delaying Time to CRPC

Feb 2022

Reinforcing Consistent Testosterone Suppression in ADT

Jan 2022

E. David Crawford, MD, Scott B. Sellinger, MD, and Paul R. Sieber, MD, discuss reinforcing consistent testosterone suppression in ADT and the role of triptorelin.

Presentations from the 1st Annual Advances in Men’s Health

Oct 2021

These lectures were presented during the 1st Annual Advances in Men's Health conference in August 22-25, in Whitefish, Montana.

Presentations from the 31st Annual International Prostate Cancer Update

Aug 2021

These lectures were presented during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Lecture Series: Leveraging the Electronic Medical Record to Improve Prostate Cancer Care

Aug 2021

In a GRU exclusive series, Franklin Gaylis, MD, FACS, discusses how the urology field can use the electronic medical record, or EMR, to improve adherence to best medical practices in prostate cancer care.

Screening and Prevention of Prostate Cancer 2021 Series

Jul 2021

In a GRU exclusive series, Sigrid V. Carlsson, MD, PhD, MPH, discusses PSA screens, biopsy, and MRI for early detection.

Androgen Society 3rd Annual Meeting Review with Abraham Morgentaler, MD, FACS

Jul 2021

In a GRU exclusive, Abraham Morgentaler, MD, FACS, Associate Clinical Professor of Urologic Surgery at Harvard University, reviews lectures from all three days of the 3rd Annual Androgen Society meeting.

Presentations from the 4th International Bladder Cancer Update

May 2021

These lectures were presented during the 4th Annual International Bladder Cancer Update on April 28.

Active Surveillance 2021 with Laurence Klotz, MD, FRCSC

Mar 2021

In a GRU exclusive, Laurence Klotz, MD, FRCSC, Professor of Surgery and holder of the Sunnybrook Chair of Prostate Cancer Research at the University of Toronto, gives three Platinum Lectures on the current state of active surveillance for prostate cancer.

Upcoming Live & Virtual Events

Plan your next urology meeting, CME activity or virtual conference now.

28th Annual Innovations in Urologic Practice

Inn and Spa at Loretto
Santa Fe, New Mexico
September 20-22, 2024

27th Southwest Prostate Cancer Symposium

Westin Kierland Resort
Scottsdale, Arizona
October 17-19, 2024

12th Urology Today Conference

Omni Grove Park Inn
Asheville, North Carolina
October 25-27, 2024

View All